Christoph Kapitza Selected Research

BIM 51077

7/2009

Treatment with the human once-weekly glucagon-like peptide-1 analog taspoglutide in combination with metformin improves glycemic control and lowers body weight in patients with type 2 diabetes inadequately controlled with metformin alone: a double-blind placebo-controlled study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Christoph Kapitza Research Topics

Disease

25	Type 2 Diabetes Mellitus (MODY) 01/2022 - 12/2002
11	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2021 - 01/2003
4	Body Weight (Weight, Body) 10/2021 - 07/2009
3	Hypoglycemia (Reactive Hypoglycemia) 10/2017 - 07/2010
2	Gastroesophageal Reflux (GERD) 01/2022 - 01/2020
2	Weight Loss (Weight Reduction) 08/2012 - 07/2009
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 01/2022
1	Gastritis 01/2022
1	Insulin Resistance 05/2018
1	Pain (Aches) 01/2018
1	Obesity 10/2017
1	Hypertension (High Blood Pressure) 02/2016
1	Nausea 08/2012
1	Wounds and Injuries (Trauma) 01/2003
1	Inflammation (Inflammations) 01/2003

Drug/Important Bio-Agent (IBA)

13	Insulin (Novolin)FDA Link 01/2022 - 12/2002
12	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 06/2004
8	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2022 - 07/2009
8	Insulin Glargine (Lantus)FDA Link 01/2020 - 06/2004
6	Metformin (Glucophage)FDA LinkGeneric 01/2020 - 07/2009
5	Insulin Lispro (Humalog)FDA Link 01/2022 - 08/2009
5	lixisenatideIBA 01/2020 - 07/2015
5	Liraglutide FDA Link 01/2020 - 03/2011
3	LinagliptinIBA 01/2022 - 02/2016
3	semaglutideIBA 01/2022 - 05/2015
3	Insulin Aspart (NovoLog)FDA Link 01/2021 - 01/2008
2	Glucagon-Like Peptide-1 Receptor AgonistsIBA 10/2021 - 01/2020
2	SolutionsIBA 01/2021 - 01/2017
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 12/2015 - 01/2003
1	IncretinsIBA 01/2022
1	Gastric Inhibitory Polypeptide (Glucose Dependent Insulinotropic Peptide)IBA 01/2022
1	insulin aspart protamine drug combination 30:70 insulin aspartIBA 01/2021
1	Glucagon (Glukagon)FDA Link 01/2020
1	AcidsIBA 01/2020
1	dapagliflozinIBA 05/2018
1	InsulinsIBA 10/2017
1	ProfilIBA 01/2017
1	dulaglutideIBA 01/2017
1	empagliflozinIBA 01/2017
1	Short-Acting InsulinIBA 01/2017
1	LY2963016 insulin glargineIBA 01/2017
1	Biomarkers (Surrogate Marker)IBA 01/2017
1	SAR342434IBA 01/2017
1	Dipeptidyl-Peptidase IV InhibitorsIBA 02/2016
1	Combined Oral ContraceptivesIBA 05/2015
1	Gastrointestinal Hormones (Hormones, Gastrointestinal)IBA 08/2012
1	AntralIBA 08/2012
1	glimepiride (Amarel)FDA LinkGeneric 08/2012
1	Acetaminophen (Paracetamol)FDA LinkGeneric 08/2011
1	GlucokinaseIBA 11/2010
1	piragliatinIBA 11/2010
1	Blood Glucose (Blood Sugar)IBA 07/2010
1	Sitagliptin Phosphate (Januvia)FDA Link 07/2010
1	Exenatide (Byetta)FDA Link 07/2010
1	taspoglutideIBA 07/2009
1	BIM 51077IBA 07/2009
1	Isophane Insulin (NPH Insulin)FDA Link 06/2004
1	Insulin Detemir (Levemir)FDA Link 06/2004

Therapy/Procedure

3	Glycemic Control 10/2017 - 07/2009
2	Aftercare (After-Treatment) 01/2022 - 10/2021
2	Therapeutics 01/2017 - 07/2010
1	Injections 01/2018
1	Subcutaneous Infusions 01/2008
1	Subcutaneous Injections 08/2004
1	Catheters 01/2003
1	Nebulizers and Vaporizers (Inhaler) 12/2002